US 7897340
Use of tumor susceptibilty gene 101 (TSG 101) as a prognostic and diagnostic marker
granted A61PA61P35/00
Quick answer
US patent 7897340 (Use of tumor susceptibilty gene 101 (TSG 101) as a prognostic and diagnostic marker) held by The Board of Regents of the University of Texas System expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P35/00